BioCentury
ARTICLE | Financial News

Inspyr completes private placement of convertible preferred stock and warrants

December 14, 2016 10:58 PM UTC

Inspyr raised $1 million through the sale of about 1,000 shares of series B convertible preferred stock at $1,000 in a private placement to institutional and accredited investors. The shares initially...

BCIQ Company Profiles

Inspyr Therapeutics Inc.